These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28986511)

  • 1. Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease.
    López-Picón FR; Snellman A; Eskola O; Helin S; Solin O; Haaparanta-Solin M; Rinne JO
    J Nucl Med; 2018 Mar; 59(3):509-515. PubMed ID: 28986511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chaney A; Cropper HC; Johnson EM; Lechtenberg KJ; Peterson TC; Stevens MY; Buckwalter MS; James ML
    J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography.
    Rejc L; Gómez-Vallejo V; Joya A; Arsequell G; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Iglesias L; Capetillo-Zarate E; Ramos-Cabrer P; Martin A; Llop J
    Alzheimers Res Ther; 2022 Jun; 14(1):80. PubMed ID: 35676734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
    Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M
    J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model.
    Sacher C; Blume T; Beyer L; Peters F; Eckenweber F; Sgobio C; Deussing M; Albert NL; Unterrainer M; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Brzak I; Neumann U; Saito T; Saido TC; Bartenstein P; Rominger A; Herms J; Brendel M
    J Nucl Med; 2019 Dec; 60(12):1787-1793. PubMed ID: 31302633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    James ML; Belichenko NP; Shuhendler AJ; Hoehne A; Andrews LE; Condon C; Nguyen TV; Reiser V; Jones P; Trigg W; Rao J; Gambhir SS; Longo FM
    Theranostics; 2017; 7(6):1422-1436. PubMed ID: 28529627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid load and translocator protein 18 kDa in APPswePS1-dE9 mice: a longitudinal study.
    Sérrière S; Tauber C; Vercouillie J; Mothes C; Pruckner C; Guilloteau D; Kassiou M; Doméné A; Garreau L; Page G; Chalon S
    Neurobiol Aging; 2015 Apr; 36(4):1639-1652. PubMed ID: 25680265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.
    Dickens AM; Vainio S; Marjamäki P; Johansson J; Lehtiniemi P; Rokka J; Rinne J; Solin O; Haaparanta-Solin M; Jones PA; Trigg W; Anthony DC; Airas L
    J Nucl Med; 2014 Mar; 55(3):466-72. PubMed ID: 24516258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging.
    Hommet C; Mondon K; Camus V; Ribeiro MJ; Beaufils E; Arlicot N; Corcia P; Paccalin M; Minier F; Gosselin T; Page G; Guilloteau D; Chalon S
    Dement Geriatr Cogn Disord; 2014; 37(1-2):1-18. PubMed ID: 24107621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of brain regions predicting epileptogenesis by serial [
    Russmann V; Brendel M; Mille E; Helm-Vicidomini A; Beck R; Günther L; Lindner S; Rominger A; Keck M; Salvamoser JD; Albert NL; Bartenstein P; Potschka H
    Neuroimage Clin; 2017; 15():35-44. PubMed ID: 28462087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
    Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
    Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
    Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A
    J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.